Member Info for 1eyedman

I agree that LTIP should be paid out of profit not by issuing more shares. Whilst going down the share route is fine if the issue is a fraction of 1% this is a not insignificant dilution. It neatly sums up the profligate issuance of shares prevalent on AIM where significant numbers are issued like confetti. Not over happy with the scale of this myself. It tends to put the recipients in a cant really lose but can win big situation.

I guess if the share price trebles and the payout would equate to over 10m we would still be pretty happy., if it falls its a dilution used to supplement already impressive salaries. If we assume 300 employees for simplicity I believe its around 12 thousand (£) each although I suspect heavily biased towards management in reality. Any employee share scheme I have ever participated in in the real world involved me paying for the shares myself albeit at a discount. Which you would happily do if you believed in the company prospects.

@GracieP. Thank you for the information in your post and good luck with your other investments should you not dip your toe in the Creo water :).

Another good news RNS and as I've mentioned I really hope from a humane perspectives that the products continue to give good outcomes to those that require this surgery. From a business perspective I'm slightly concerned that no matter how good the product are the training barriers involved may continue to slow the path to profit. Lets hope once those trained are passing the knowledge on others things start to cascade in a positive way. Very interesting potted history Theorist, lets hope some lessons have been learnt!.

Unexpected share issues are the bane of AIM stocks and it is surprising how often you don't see them coming. Its a fact of life that share issues on AIM are seen as a cash machine to get a company to profitability. As long as that profitability arrives its not quite so bad but its hard to judge the odds of this as most RNS are full of smoke and mirrors unfortunately. Whilst it would be rather wonderful if Intuitive or anyone else showed interest its unlikely in my personal opinions. Unless the technology is fantastic its cheaper for any interested party to wait and see if the company fails to secure enough funding to win the race and pick up the pieces out of administration where the debts are written off. Should the company win the race to profitability the picture is changed considerably.

That's brilliant both of you many thanks!. Just gives me a bit of context as to how things might go (all things being well of course) just to get back to where the MCAP was historically. I bought in around the 30p mark so no champagne corks yet but maybe the odd beer or two on the back of things so far :).

The crowd go wild!. Or are quietly county their cash. I wonder can any of the long term holders tell me very roughly what the MCAP of the company was back in (say) March '22 when the share price was around £2.20?. Whilst its easy enough to look up a historical share price the issuing of shares on AIM stocks mean historical MCAPS are more difficult to work out. A best guess ballpark would be fine or even a best (educated) guess at the highest ever MCAP so far?.

Cheers

Starresnstoff. Useful link thank you.

David. With respect to time scale. No idea in all honesty,I would guess months rather than weeks or years. The NICE website does mention 39weeks for technological appraisal process. Seems an odd number and is probably an average. The outcome is obviously very important either way. Good luck with your investment!.

Sorry my wording was bad in my post. I was referring to a couple of £10k share buys which is pretty chunky as volumes are pretty thin. But I agree the ongoing revenue from sales from hospitals embracing the devices is encouraging.

A lot of work to do to get more hospitals on board with the devices but so far so good. Couple of fairly decent buys someone likes it.

Another useful link-thank you. Nice to see the last raise confidently referred to as 'final', although it risks something of a credibility issue should this not prove to be the case.
@Faicj -Welcome and GL I hope you make lots of money :).

Potash was a good bet for me and the value of potash increased when fertilisers became short. There was just one tiny tiny problem which was the plant to process the extraction did not work as designed. The big lenders had first call on the considerable infrastructure that has been built (after several placings etc.) so I guess it was a no brainer to them to turn off the financial taps and let the company fail. I have to agree that Australian CEO's seem to have more than their fair share of bad luck shall we say :).
At least here we have products already for sale and we just have to hope for further sales and successful use of the products. I should have learnt some time ago from my experience with gold miners, the only ones who have earnt me a bit of profit are ones that were already producing before I bought in (as opposed to being a hopeful hole in the ground). Mind you I mustn't get too enthusiastic or Ill end up buying some more CREO when I get some 'spare' cash.

Troajan
Yes it’s odd. Mind you when it was clear that my last AIM investment was going to go under quite a few obvious rampers appeared which pretty disappointing. Another one I had and sold was a miner endlessly waiting for a licence, I did not post on that board but sometimes check in and the same people are there years later still waiting for the licence. Very civilised around here though!.

Gl yourself

“A very busy board” :). It’s quality that counts.

Appreciate the links though.

Agreed, positive forward looking RNS. For balance though the elephant in the room is the yearly loss. This will need to turn round pretty fast to avoid further dilution. No deal breakers though which is a good start!.
GL

Interesting and informative RNS. It may not have much immediate effect on SP as the studies look pretty long term which I guess is to be expected. It would be excellent if the device proves to be effective for issues not currently eligible for surgery (from RNS). From a human perspective I mean in this instance. What a useful tech this could turn out to be.

'A surprise either way would have a dramatic impact on the sp.'

Also totally agree with this. I feel it is a positive to have the product already and the race to profit depends on driving sales and training. Things can go very wrong or right depending on whether milestones are met. The company still has a fairly decent market cap though, the real worry comes when a company is worth buttons but still needs to raise. Which CREO clearly doesn't unless they splash cash on a an acquisition.

@ Theorist. Well had I put my shirt on SO4 I would be half naked now which is not a good thought!. I actually thought they might get potash process over the line but in keeping with many AIM stocks ran out of money and the well of share issues had run dry. Still that is history and I’m back in the fun zone.. Would not have bought in to CREO if the story did not make some sense. I tend to use these boards occasionally but not as an investment aid. If you have seen my SO4 posts hopefully it’s pretty clear that although I like to be positive (otherwise why buy the share) I don’t have blind faith when the writing is on the wall that a company is falling over. Hopefully not something we will experience in this case :).

I decided to burden this share with a small investment after becoming interested on the back of a MF article. Buying after a successful placing seemed as good a time as any in the hope there wont be another one for a while!. This seems like another race to profit before running out of money (sorry to state the obvious!) but I do like a gamble.
Good luck to us!

Edward75. I hope we get the positive outcome you describe and you make valid points about how close the company has got to production. I fear the race against funding is looking lost but obviously there are a range of possible outcomes. GL also.
I’m much more comfortable with reasoned positivity than the ludicrous multi bagger tosh that was around prior to suspension.

I cant see the latest RNS as anything else other than an indication that the company is a further step closer to administration. Even the wording seems pretty pessimistic. At least the suspension on AIM will save anyone getting sucked into the fantasy world that this is a short term multi-bagger.
I'm actually wondering if the lenders that appear to 'own' the infrastructure should the worst happen, might still get a little singed. This kit would only be useful to anyone who wants to attempt to produce SOP from the lakes. It would be interesting to see where this ended up if SO4 falls over. One possibility is another operator over paying the current lender for the plant etc. on the basis that they (Tauris) will helpfully lend the new owner some cash. Purely on the basis of course that any new operator is in a position to soak their shareholders for a placing to help the funding. Bit cynical maybe?.